Ariadna Cuevas Fiallo

Title: Innovations in Cancer Therapy by Ariadna Cuevas Fiallo

Introduction

Ariadna Cuevas Fiallo is a notable inventor based in Ciudad de la Habana, Cuba. She has made significant contributions to the biotechnology sector, particularly in human healthcare. Her work focuses on developing innovative solutions for cancer treatment, showcasing her dedication to improving patient outcomes.

Latest Patents

Ariadna holds a patent for a homogeneous vaccine composition comprising a conjugate of EGF and P64K for the treatment of tumors. This invention describes a vaccine composition intended for therapeutic use in cancer patients. The active principle of this vaccine is a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and the combining protein P64K. The invention outlines specific conditions for performing a conjugation reaction, ensuring that the chemical conjugate is produced in a controlled and reproducible manner. Additionally, it details a method for purifying the chemical conjugate, which enhances the purity of the therapeutic composition and surprisingly increases its immunogenic activity. This results in significant increases in the anti-EGF antibody titers in humans. The invention also provides a methodology for producing a vaccine preparation with multiple dose presentations, allowing for increased immunization doses without raising the frequency or number of immunization sites. This innovative approach represents a significant advancement in healthcare methods for cancer therapy.

Career Highlights

Ariadna has worked with esteemed organizations such as the Centro de Inmunología Molecular, where she has contributed to groundbreaking research and development in immunology. Her expertise and dedication have positioned her as a key figure in the field of biotechnology.

Collaborations

Throughout her career, Ariadna has collaborated with talented individuals, including Gryssell María Rodríguez Martínez and Lisel Viña Rodríguez. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ariadna Cuevas Fiallo's contributions to cancer therapy through her innovative vaccine composition highlight her commitment to advancing human healthcare. Her work exemplifies the potential of biotechnology to transform treatment options for cancer patients.